Are patients with HHV-8 associated Castleman disease successfully treated with rituximab at risk of subsequently developing HHV-8 negative (idiopathic) Castleman disease?

Are patients with HHV-8 associated Castleman disease successfully treated with rituximab at risk of subsequently developing HHV-8 negative (idiopathic) Castleman disease?

Introduction: Multicentric Castleman disease (MCD) is a lymphoproliferative disorder characterized by lymph node histopathology and systemic symptoms. To our knowledge, there are no descriptions in the literature of long-term outcomes of human herpesvirus-8 (HHV-8)-associated MCD. Case Description: ...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Gavin Ha, Kelsey Kwong, Bryce Tanaka, Yoshito Nishimura, Christina Chong
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: SMC MEDIA SRL 2023-06-01
Seri Bilgileri:European Journal of Case Reports in Internal Medicine
Konular:
multicentric castleman disease
human immunodeficiency virus
interleukin 6
siltuximab
Online Erişim:https://www.ejcrim.com/index.php/EJCRIM/article/view/3904

Internet

https://www.ejcrim.com/index.php/EJCRIM/article/view/3904

Benzer Materyaller